325 related articles for article (PubMed ID: 26517858)
1. Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial.
Schukro RP; Oehmke MJ; Geroldinger A; Heinze G; Kress HG; Pramhas S
Anesthesiology; 2016 Jan; 124(1):150-8. PubMed ID: 26517858
[TBL] [Abstract][Full Text] [Related]
2. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
[TBL] [Abstract][Full Text] [Related]
5. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials.
Williamson OD; Schroer M; Ruff DD; Ahl J; Margherita A; Sagman D; Wohlreich MM
Clin Ther; 2014 Apr; 36(4):544-51. PubMed ID: 24650448
[TBL] [Abstract][Full Text] [Related]
6. A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy.
Majdinasab N; Kaveyani H; Azizi M
Drug Des Devel Ther; 2019; 13():1985-1992. PubMed ID: 31354243
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.
Skljarevski V; Ossanna M; Liu-Seifert H; Zhang Q; Chappell A; Iyengar S; Detke M; Backonja M
Eur J Neurol; 2009 Sep; 16(9):1041-8. PubMed ID: 19469829
[TBL] [Abstract][Full Text] [Related]
9. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial.
Nalamachu S; Hale M; Khan A
J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
Skljarevski V; Zhang S; Desaiah D; Alaka KJ; Palacios S; Miazgowski T; Patrick K
J Pain; 2010 Dec; 11(12):1282-90. PubMed ID: 20472510
[TBL] [Abstract][Full Text] [Related]
11. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
12. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
[TBL] [Abstract][Full Text] [Related]
13. Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.
Smith EM; Pang H; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Fadul CE; Knox C; Le-Lindqwister N; Gilman PB; Shapiro CL;
JAMA; 2013 Apr; 309(13):1359-67. PubMed ID: 23549581
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Duloxetine in Patients with Central Post-stroke Pain: A Randomized Double Blind Placebo Controlled Trial.
Mahesh B; Singh VK; Pathak A; Kumar A; Mishra VN; Joshi D; Chaurasia RN
Pain Med; 2023 Jun; 24(6):610-617. PubMed ID: 36409018
[TBL] [Abstract][Full Text] [Related]
15. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis.
Vollmer TL; Robinson MJ; Risser RC; Malcolm SK
Pain Pract; 2014 Nov; 14(8):732-44. PubMed ID: 24152240
[TBL] [Abstract][Full Text] [Related]
18. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
20. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
Peloso PM; Fortin L; Beaulieu A; Kamin M; Rosenthal N;
J Rheumatol; 2004 Dec; 31(12):2454-63. PubMed ID: 15570651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
